Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease

Annals of Neurology
Kevin St P McNaughtC Warren Olanow

Abstract

Environmental toxins have been implicated in the etiology of Parkinson's disease. Recent findings of defects in the ubiquitin-proteasome system in hereditary and sporadic forms of the illness suggest that environmental proteasome inhibitors are candidate PD-inducing toxins. Here, we systemically injected six doses of naturally occurring (epoxomicin) or synthetic (Z-lle-Glu(OtBu)-Ala-Leu-al [PSI]) proteasome inhibitors into adult rats over a period of 2 weeks. After a latency of 1 to 2 weeks, animals developed progressive parkinsonism with bradykinesia, rigidity, tremor, and an abnormal posture, which improved with apomorphine treatment. Positron emission tomography demonstrated reduced carbon-11-labeled 2beta-carbomethoxy-3beta-(4-fluorophenyl)tropane (CFT) binding to dopaminergic nerve terminals in the striatum, indicative of degeneration of the nigrostriatal pathway. Postmortem analyses showed striatal dopamine depletion and dopaminergic cell death with apoptosis and inflammation in the substantia nigra pars compacta. In addition, neurodegeneration occurred in the locus coeruleus, dorsal motor nucleus of the vagus, and the nucleus basalis of Meynert. At neurodegenerative sites, intracytoplasmic, eosinophilic, alpha-synuclein/...Continue Reading

References

Aug 1, 1991·Journal of Neurochemistry·H H Kalir, C Mytilineou
Oct 1, 1993·Research in Microbiology·J C EnsignC A Yallop
Mar 1, 1996·Journal of Neuropathology and Experimental Neurology·L S Forno
May 16, 1998·The Journal of Biological Chemistry·G Fenteany, S L Schreiber
Oct 17, 1998·Nature·E LeroyM H Polymeropoulos
Nov 24, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·J O RinneO Solin
Dec 2, 2000·Nature Neuroscience·R BetarbetJ T Greenamyre
May 2, 2001·Nature Reviews. Neuroscience·M F Beal
Jun 16, 2001·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·L KozlowskiH Ostrowska
Jul 5, 2001·Environmental Research·A PriyadarshiS S Priyadarshi
Aug 22, 2001·Chemistry & Biology·A F Kisselev, A L Goldberg
Jan 10, 2002·Proceedings of the National Academy of Sciences of the United States of America·Lars M BjorklundOle Isacson
Aug 9, 2002·Neuroreport·Kevin St P McNaughtC Warren Olanow
Dec 11, 2002·The European Journal of Neuroscience·Kevin St P McNaughtC Warren Olanow
Dec 25, 2002·Neurobiology of Aging·Heiko BraakEva Braak
Dec 31, 2002·Experimental Neurology·Kevin St P McNaughtC Warren Olanow
Jan 29, 2003·The Journal of Biological Chemistry·Heather SnyderBenjamin Wolozin
Feb 1, 2003·Journal of Neurochemistry·Günter U HöglingerEtienne C Hirsch
Apr 1, 2003·Annals of Neurology·Kevin St P McNaught, C Warren Olanow
Aug 19, 2003·The Journal of Biological Chemistry·George K TofarisMaria Grazia Spillantini
Nov 1, 2003·Science·Ted M Dawson, Valina L Dawson
Nov 1, 2003·Science·A B SingletonK Gwinn-Hardy
Jan 1, 2004·The Journal of Biological Chemistry·Nihar Ranjan JanaNobuyuki Nukina
Feb 10, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Nicolas LapointeFrancesca Cicchetti

❮ Previous
Next ❯

Citations

Apr 28, 2006·Experimental Brain Research·Heather L MelroseMatthew J Farrer
Mar 6, 2008·Acta Neuropathologica·Kelly Del Tredici, Heiko Braak
Oct 28, 2005·Journal of Neural Transmission·B ScholtissenA F G Leentjens
Apr 7, 2007·Apoptosis : an International Journal on Programmed Cell Death·Luena PapaPatricia Rockwell
Jan 9, 2009·Apoptosis : an International Journal on Programmed Cell Death·Tomohiro Nakamura, Stuart A Lipton
Jun 15, 2007·Cancer Causes & Control : CCC·Jane A DriverGiancarlo Logroscino
Jan 8, 2010·Cancer Causes & Control : CCC·Archna BajajEva S Schernhammer
Jul 7, 2006·Cellular and Molecular Neurobiology·Toshi Nagatsu, Makoto Sawada
Mar 15, 2008·Cellular and Molecular Neurobiology·Naoto KadoguchiTsutomu Araki
Apr 17, 2009·Cellular and Molecular Neurobiology·Takuya OshikawaTsutomu Araki
Jul 2, 2008·Current Neurology and Neuroscience Reports·Tiffini Voss, Bernard Ravina
Dec 25, 2007·Journal of Molecular Neuroscience : MN·E M Hol, W Scheper
Aug 5, 2009·Neurotoxicity Research·Melanie Dyllick-BrenzingerAnurag Tandon
Jun 14, 2005·Biochemical and Biophysical Research Communications·Xiong ZhangWeidong Le
Mar 10, 2005·Experimental Neurology·James W Geddes
Jun 10, 2005·Experimental Neurology·Lixia LuAndreas Hartmann
Mar 26, 2005·Brain Research. Molecular Brain Research·Mika ShimojiTed M Dawson
May 26, 2005·Trends in Neurosciences·Andrew B WestTed M Dawson
Sep 17, 2005·Nature Reviews. Molecular Cell Biology·Christopher A Ross, Michelle A Poirier
Dec 21, 2006·Nature Reviews. Neuroscience·Michelle L BlockJau-Shyong Hong
Sep 27, 2008·The Journal of Biological Chemistry·Arthur P ChouJeff M Bronstein
Oct 16, 2007·Journal of Toxicology and Environmental Health. Part a·Wonsuk Yang, Evelyn Tiffany-Castiglioni
Feb 21, 2006·Antioxidants & Redox Signaling·Qunxing DingJeffrey N Keller
Oct 27, 2007·Antioxidants & Redox Signaling·Tomohiro Nakamura, Stuart A Lipton
Feb 27, 2009·Antioxidants & Redox Signaling·Jeanne M M TanKah-Leong Lim
May 9, 2009·Antioxidants & Redox Signaling·Zhi Yao, Nicholas W Wood
Apr 1, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jinte MiddeldorpElly M Hol
Jun 28, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·G Linazasoro
Sep 19, 2006·Biochemistry. Biokhimii︠a︡·O A Buneeva, A E Medvedev
Jul 19, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·S M HagueO Bandmann
Jun 15, 2005·Annual Review of Biochemistry·Mark R Cookson
Jul 19, 2005·Annual Review of Neuroscience·Darren J MooreTed M Dawson
Nov 6, 2012·Parkinson's Disease·Ana María Sánchez-PérezMaría Trinidad Herrero
Feb 19, 2009·Stereotactic and Functional Neurosurgery·Chaoshi NiuXianming Fu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Atypical Parkinsonism (MDS)

Atypical Parkinsonism presents with the same signs and symptoms of Parkinson's disease, but do not respond to typical Parkionson's disease treatment with levodopa. Atypical Parkinsonism is thought to be associated with abnormal protein buildup within brain cells. Here is the latest on Atypical Parkinsonism.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis